> top > docs > PubMed:27319011 > annotations

PubMed:27319011 JSONTXT

Annnotations TAB JSON ListView MergeView

chenxin_473849_800_3

Id Subject Object Predicate Lexical cue
T1 136-160 DP denotes Type 2 Diabetes Mellitus
T10 1429-1441 CI denotes lixisenatide
T11 1705-1717 CI denotes lixisenatide
T12 837-846 CI denotes metformin
T13 1569-1578 CI denotes metformin
T15 1130-1142 CI denotes Lixisenatide
T16 110-122 CI denotes Lixisenatide
T17 883-890 CI denotes placebo
T18 816-823 CI denotes placebo
T19 1202-1209 CI denotes placebo
T2 314-338 DP denotes type 2 diabetes mellitus
T3 340-344 DP denotes T2DM
T4 639-643 DP denotes T2DM
T5 1535-1539 DP denotes T2DM
T6 796-808 CI denotes lixisenatide
T7 525-537 CI denotes lixisenatide
T8 756-768 CI denotes lixisenatide
T9 863-875 CI denotes lixisenatide
T20 924-933 CI denotes metformin

yangbin123xm_800_3

Id Subject Object Predicate Lexical cue
T10 796-808 CI denotes lixisenatide
T11 1130-1142 CI denotes Lixisenatide
T12 1429-1441 CI denotes lixisenatide
T13 1705-1717 CI denotes lixisenatide
T14 136-160 DP denotes Type 2 Diabetes Mellitus
T15 314-338 DP denotes type 2 diabetes mellitus
T16 837-846 CI denotes metformin
T17 1569-1578 CI denotes metformin
T18 883-890 CI denotes placebo
T19 816-823 CI denotes placebo
T20 1202-1209 CI denotes placebo
T3 340-344 DP denotes T2DM
T4 639-643 DP denotes T2DM
T5 1535-1539 DP denotes T2DM
T6 110-122 CI denotes Lixisenatide
T7 525-537 CI denotes lixisenatide
T8 756-768 CI denotes lixisenatide
T9 863-875 CI denotes lixisenatide
T21 924-933 CI denotes metformin